Continuous Glucose Monitor Device

DEVICE2 trials

Sponsors

Signos Inc

Conditions

Central ObesityDiabetes Mellitus, Type 2Glucose IntoleranceInsulin ResistanceMetabolic Glucose DisordersMetabolic SyndromePre-diabetesWeight Loss

Unknown Phase

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform

Active, not recruitingNCT05121844

Signos IncCentral Obesity, Glucose Intolerance, Metabolic Glucose Disorders +3

Start: 2021-11-02End: 2027-11-01Target: 31187Updated: 2025-08-24

Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Active, not recruitingNCT05874635

Signos IncCentral Obesity, Diabetes Mellitus, Type 2, Glucose Intolerance +4

Start: 2023-05-11End: 2029-05-10Target: 20000Updated: 2025-08-29